Marcos de Lima, MD
Ohio State University · UT MD Anderson Cancer Center · M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marcos de Lima, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:19 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06180863 · Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) PatientsYale University · withdrawn · Acute Myeloid Leukemia · principal investigator
- Ph2NCT01003054 · Autologous Transplantation for Chronic Myelogenous LeukemiaM.D. Anderson Cancer Center · completed · Chronic Myelogenous Leukemia · study chair
- Ph1/Ph2NCT00506922 · Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMTM.D. Anderson Cancer Center · completed · Leukemia, Lymphoma · principal investigator
- Ph2NCT00446173 · Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaM.D. Anderson Cancer Center · withdrawn · Leukemia · principal investigator
- Ph1NCT00350818 · Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)M.D. Anderson Cancer Center · completed · Myelodysplastic Syndrome, Leukemia · principal investigator
- Ph1/Ph2NCT00038831 · Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDSM.D. Anderson Cancer Center · completed · Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia · principal investigator
- Ph2/Ph3NCT00038805 · Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)M.D. Anderson Cancer Center · terminated · Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)T32CA233414 · NCI · YALE UNIVERSITY · PI Eric P. Winer · fiscal years 2019 to 2026Named on NCT06180863
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.